• If this is your first visit, be sure to check out the FAQ & read the forum rules. To view all forums, post or create a new thread, you must be an AAPC Member. If you are a member and have already registered for member area and forum access, you can log in by clicking here. If you've forgotten the password it can be reset on our sign in section by entering your registered Email Address or Username here. To start viewing messages, select the forum that you want to visit from the selection below..

Wiki mdm

Create Wiki
A

anggand@aol.com

Networker
Messages
64
Best answers
0
We do Drug testing in house at our pain management office and also document the results in our charts, im wondering if we get a point under clinical lab and 2 points for determining what the results are? ( direct view of specimen)...... also would it be considered high risk under drug terapy requiring intensive monitoring?
 
Last edited:
Giving credit for the lab, I would......I am sort of on the line about the independent review, does he mention the results?

On Risk, absolutely NO! Drug therapy requiring extensive monitoring is for the drugs that have to be monitored for levels that can become toxic and cause poisioning/death. Some examples are: depakote, dilantin, lithium, and I even consider Coumadin (some do not count this but Coumadin is highly monitored). Conducting drug testing in a pain clinic is to check for non-approved drugs being taken by the patient, correct? At least they are in the Pain Clinic that I work with.

I would count that more under prescription drug management. Unless they are on a Parenteral Controlled Substance!
 
thank you for responding, you gave me alot of helpful information and yes he does mention the results in the chart note.
 
You must log in or register to reply here.
Top